Patient information leaflet errors can, in the worst-case scenarios, cause severe problems for those who have used the wrong medication or used meds incorrectly due to the error.
When these scenarios happen, a recall will usually be launched and announced via the Medicines and Healthcare products Regulatory Agency (MHRA). Information about the recall will normally be distributed so that patients can be made aware, but this won’t always stop an adverse incident from occurring.
With this in mind, here’s a little advice about what to do if you have suffered harm as a result of following the incorrect information for medication or a product in general.
The vaginal mesh scandal has hit the news again this week as we continue to represent victims claiming compensation for pelvic mesh procedures that have gone wrong.
The invasive surgical procedure was under a widespread pause last year following further reviews into the safety and efficacy of the devices. In April this year, revised guidelines were released by NICE (The National Institute for Health and Care Excellence), which many have argued do not go far enough.
We know from years of experience and from the clients that we help that the impact of mesh gone wrong can be absolutely awful.
The Marriott data breach fine to be issued by the Information Commissioner’s office (ICO) from the breach that was discovered last year is set to be £99m.
News of the penalty came within days of the record-setting provisional fine that’s been set for the British Airways data breach in the sum of £183m. GDPR allows the regulator to fine organisations up to 4% of their global annual turnover, and for large organisations who are guilty of significant breaches of important data laws, monetary penalties – as seen in these first two big ones – can be substantial.
Victims of the data breach can also be entitled to claims compensation, but this is a separate matter to any fine that’s issued by the ICO.
The provisional £183m British Airways data breach fine means that the airline is set to be severely punished for the 2018 cyber-attacks that took place.
Fines can be levied at up to 4% of a company’s global annual turnover, and in the BA case, the fine is understood to equate to 1.5% of their 2017 turnover.
The financial penalties that can be issued under GDPR are far higher than what they used to be under its predecessor, the Data Protection Act. But what about compensation for the hundreds of thousands of victims whose information was compromised?
A medical device alert has been issued and published by the MHRA in relation to Ethicon surgical staplers, which have reportedly caused injury to some patients.
It’s understood that there’s a risk that some of the devices manufactured from March 2018 have not been working properly. Reported issues include the devices misfiring or failing to fire the staples during surgery. The MHRA (Medicines and Healthcare products Regulatory Agency) say that there has been increased complaints of malformed stables with some devices being returned.
With this issue involving invasive surgery, the alert is one that needs to be taken incredibly seriously.
In some cases, women feel that the only way forward is to opt for private mesh removal surgery when suffering problems after a vaginal mesh procedure.
We represent a number of women who are claiming for compensation having suffered pelvic mesh complications. We know how bad it can be, especially when some patients are left unable to walk or work at all. We know of cases where women have struggled to get help and advice form the NHS, and cases where patients are waiting over a year for referrals.
You may feel that you have to take matters into your own hands and go for private treatment and surgery. This can be factored into a claim for compensation.
The information for thousands more victims of the 2015 TalkTalk data breach incident have been found online as the number of victims expands.
We’re representing a group of victims who are claiming for data breach compensation who were affected by the TalkTalk hack of 2015. This is one of the over 40 different group and multi-party actions we’re fighting for justice in on a No Win, No Fee basis.
If you are one of the additional 4,545 victims of the incident, or if you were notified previously and you’ve yet to start your case, make sure you contact us ASAP.
Following the criticism over the new guidelines that came out last month, we’ve received further enquiries from people asking for advice about TVT surgery claims.
With the issues surrounding vaginal mesh in the news again, here’s some advice for you if you’ve yet to speak to anyone about your options for compensation.
One of the first things we often remind people about is to make sure that you seek advice as soon as you can. There can be a number of timeframes to start a case in a legal action of this nature. Leaving it too late can be the difference between receiving tens of thousands of pounds or getting absolutely nothing as a victim of TVT surgery gone wrong.
The Raindrop Near Vision Inlay recall has been initiated due to an increased risk of corneal haze that patients implanted with the devices may experience.
A Medical Device Alert was issued via the MHRA (Medicines and Healthcare products Regulatory Agency) a few weeks ago. There’s a warning to not implant Raindrop Near Vision Inlays and to dispose of any unused stock of them.
Any patients who have already been implanted with the inlays are to be monitored, and any incidents and problems are to be reported. This recall follows the recent news coverage about the Oculentis recall, which is one of the compensation actions we’re representing people for.
You can join the legal action we’ve launched for women who are making TVT mesh claims having suffered problems and complications following their surgery.
Although different women can suffer in different ways, and each person has their own claim for compensation, we’re acting for a group that may either form into one action or remain as a multi-party action. These kinds of medical group actions are what we specialise in. We’ve recovered over £1.3m in compensation for a similar medical group action, and we’ve been appointed to the Steering Committee leading what’s set to be one of the biggest consumer actions in the UK.
When it comes to group actions, our expertise speaks for itself. Women who have yet to start TVT mesh claims may be eligible for our help today.
If you’ve yet to start your Oculentis claim, here’s some information about getting started today. It’s important to claim as soon as you can.
If you’re one of the hundreds of people who have suffered with opacification problems having been fitted with intraocular lenses manufactured by Oculentis, you may have a claim for compensation. The blind spots and cloudiness in the vision can be caused by calcification from phosphate that was previously used in the manufacturing process.
The way to correct the problem is to have further surgery for the lenses to be replaced. You may be able to claim personal injury compensation for having to undergo the further surgical procedure.
If you’ve yet to initiate your legal action for Oculentis compensation, make sure you speak to our team as soon as you possibly can.
In this type of action, there can be complicated (and multiple) time limits to claim. Missing one or more of these deadlines could mean the difference between receiving thousands of pounds in compensation or getting absolutely nothing at all.
You may be eligible to claim Oculentis compensation if you’re one of the hundreds of people affected by the recall of their intraocular lenses.